Paul J Goodfellow

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Matthew A Powell, Sara A Byron, Candice L Wellens, 2008, Cancer research.

Promoter hypermethylation of CIDEA, HAAO and RXFP3 associated with microsatellite instability in endometrial carcinomas.

Jingqin Luo, P. Goodfellow, D. Mutch, 2010, Gynecologic oncology.

Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.

P. Goodfellow, E. Hade, D. Mutch, 2016, Gynecologic oncology.

Patterns and functional implications of rare germline variants across 12 cancer types

Li Ding, Benjamin J Raphael, Benjamin J. Raphael, 2015, Nature Communications.

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Colin C Pritchard, Stephen J Salipante, Gail P Jarvik, 2012, The Journal of molecular diagnostics : JMD.

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.

Jingqin Luo, Daniel E Deatherage, Daniel E. Deatherage, 2009, Cancer research.

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

Li Ding, Rakesh Nagarajan, Ken Chen, 2011, JAMA.

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.

Matthew A Powell, Feng Gao, P. Goodfellow, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation Markers

Tim Hui-Ming Huang, Matthew A Powell, Pearlly S Yan, 2007, Clinical Cancer Research.

Use of mutation profiles to refine the classification of endometrial carcinomas

Thomas Zeng, Martin Hirst, Kane Tse, 2012, The Journal of pathology.